Last update 23 Jan 2025

JD Bioscience Co., Ltd.

Holding Company|
2017|
Seoul, South Korea
|
jdbiosci.com

Overview

Tags

Neoplasms
Other Diseases
Digestive System Disorders
Small molecule drug
Antibody drug conjugate (ADC)
Proteolysis-targeting chimeras (PROTAC)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Immune System Diseases1
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug6
Proteolysis-targeting chimeras (PROTAC)1
Antibody drug conjugate (ADC)1
Chemical drugs1
Top 5 TargetCount
PDHK(Pyruvate dehydrogenase kinase)2
HTR(5-hydroxytryptamine receptors, G protein-coupled)1
PDK4(pyruvate dehydrogenase kinase 4)1
5-HT2A receptor(Serotonin 2a (5-HT2a) receptor)1
TLR7 x TLR81

Related

12
Drugs associated with JD Bioscience Co., Ltd.
GM-60106
Target
5-HT2A receptor
Mechanism
5-HT2A receptor antagonists
Active Org.
JD Bioscience Co., Ltd.
Originator Org.
JD Bioscience Co., Ltd.
Active Indication
Nonalcoholic Steatohepatitis [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
GM-91466
Target-
Mechanism-
Active Org.
JD Bioscience Co., Ltd.
Originator Org.
JD Bioscience Co., Ltd.
Active Indication
Epilepsies, Myoclonic
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
TLR7/8 agonists(Chungnam National University)
Target
TLR7 x TLR8
Mechanism
TLR7 agonists [+1]
Active Org.
JD Bioscience Co., Ltd.
Originator Org.
JD Bioscience Co., Ltd.
Active Indication
Influenza A virus infection
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with JD Bioscience Co., Ltd.
NCT05517564
/ Unknown statusPhase 1
A Phase 1, First-in-Human, Double-blind, Placebo-controlled, Single-and Multiple-Ascending Oral Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease
100 Clinical Results associated with JD Bioscience Co., Ltd.
Login to view more data
0 Patents (Medical) associated with JD Bioscience Co., Ltd.
Login to view more data
100 Deals associated with JD Bioscience Co., Ltd.
Login to view more data
100 Translational Medicine associated with JD Bioscience Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
4
4
Preclinical
Phase 2 Clinical
1
3
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free